Emerging transcriptional mechanisms in the regulation of epithelial to mesenchymal transition and cellular plasticity in the kidney

Journal of Clinical Medicine

Volumn 5, Issue 1, 2016, Pages

  de Chiara, Letizia ^a   Crean, John ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

EMT; Kidney; Plasticity; PRC2; SMAD3; SNAI1; TGFb signaling

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; NERVE CELL ADHESION MOLECULE; OSTEOGENIC PROTEIN 1; POLYCOMB REPRESSIVE COMPLEX 2; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UVOMORULIN; VIMENTIN; ZINC FINGER PROTEIN;

CELL PLASTICITY; CHROMATIN ASSEMBLY AND DISASSEMBLY; DOWN REGULATION; END STAGE RENAL DISEASE; EPITHELIAL MESENCHYMAL TRANSITION; FIBROSIS; GENE EXPRESSION; HISTONE MODIFICATION; HUMAN; KIDNEY INJURY; NONHUMAN; ORGANOGENESIS; REVIEW; SIGNAL TRANSDUCTION;

EID: 85067220162     PISSN: None     EISSN: 20770383     Source Type: Journal    
DOI: 10.3390/jcm5010006     Document Type: Review

References (128)

1. Kalluri, R.; Weinberg, R.A. The basics of epithelial-mesenchymal transition. J. Clin. Investig. 2009, 119, 1420–1428. [CrossRef][PubMed]
2. Thiery, J.P.; Acloque, H.; Huang, R.Y.; Nieto, M.A. Epithelial-mesenchymal transitions in development and disease. Cell 2009, 139, 871–890. [PubMed]
3. Burns, W.C.; Thomas, M.C. The molecular mediators of type 2 epithelial to mesenchymal transition (EMT) and their role in renal pathophysiology. Expert Rev. Mol. Med. 2010, 12, e17. [CrossRef][PubMed]
4. Ombrato, L.; Malanchi, I. The EMT universe: Space between cancer cell dissemination and metastasis initiation. Crit. Rev. Oncog. 2014, 19, 349–361. [CrossRef][PubMed]
5. Li, R.; Liang, J.; Ni, S.; Zhou, T.; Qing, X.; Li, H.; He, W.; Chen, J.; Li, F.; Zhuang, Q. et al. A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts. Cell Stem Cell 2010, 7, 51–63. [CrossRef][PubMed]
6. Takahashi, K.; Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126, 663–676. [CrossRef][PubMed]
7. Liu, X.; Sun, H.; Qi, J.; Wang, L.; He, S.; Liu, J.; Feng, C.; Chen, C.; Li, W.; Guo, Y. et al. Sequential introduction of reprogramming factors reveals a time-sensitive requirement for individual factors and a sequential EMT-MET mechanism for optimal reprogramming. Nat. Cell Biol. 2013, 15, 829–838. [CrossRef][PubMed]
8. Rony, I.K.; Baten, A.; Bloomfield, J.A.; Islam, M.E.; Billah, M.M.; Islam, K.D. Inducing pluripotency in vitro: Recent advances and highlights in induced pluripotent stem cells generation and pluripotency reprogramming. Cell Prolif. 2015, 48, 140–156. [CrossRef][PubMed]
9. Xu, J.; Lamouille, S.; Derynck, R. TGF-b-induced epithelial to mesenchymal transition. Cell Res. 2009, 19, 156–172. [CrossRef][PubMed]
10. Zeisberg, M.; Hanai, J.; Sugimoto, H.; Mammoto, T.; Charytan, D.; Strutz, F.; Kalluri, R. BMP-7 counteracts TGF-b1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat. Med. 2003, 9, 964–968. [CrossRef][PubMed]
11. Loeffler, I.; Wolf, G. Transforming growth factor-b and the progression of renal disease. Nephrol. Dial. Transplant. 2014, 29, i37–i45. [CrossRef][PubMed]
12. Castro, N.E.; Kato, M.; Park, J.T.; Natarajan, R. Transforming growth factor b1 (TGF-b1) enhances expression of profibrotic genes through a novel signaling cascade and microRNAs in renal mesangial cells. J. Biol. Chem. 2014, 289, 29001–29013. [CrossRef][PubMed]
13. Derynck, R.; Zhang, Y.E. Smad-dependent and Smad-independent pathways in TGF-b family signalling. Nature 2003, 425, 577–584. [CrossRef][PubMed]
14. Zhang, Y.E. Non-Smad pathways in TGF-b signaling. Cell Res. 2009, 19, 128–139. [CrossRef][PubMed]
15. Nieto, M.A. Epithelial plasticity: A common theme in embryonic and cancer cells. Science 2013, 342, 1234850. [CrossRef][PubMed]
16. Jolly, M.K.; Boareto, M.; Huang, B.; Jia, D.; Lu, M.; Ben-Jacob, E.; Onuchic, J.N.; Levine, H. Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis. Front. Oncol. 2015, 5, 155. [CrossRef][PubMed]
17. Lu, M.; Jolly, M.K.; Levine, H.; Onuchic, J.N.; Ben-Jacob, E. MicroRNA-based regulation of epithelial-hybridmesenchymal fate determination. Proc. Natl. Acad. Sci. USA 2013, 110, 18144–18149. [CrossRef][PubMed]
18. Zambon, J.P.; Magalhaes, R.S.; Ko, I.; Ross, C.L.; Orlando, G.; Peloso, A.; Atala, A.; Yoo, J.J. Kidney regeneration: Where we are and future perspectives. World J. Nephrol. 2014, 3, 24–30. [CrossRef][PubMed]
19. Little, M.H.; McMahon, A.P. Mammalian kidney development: Principles, progress, and projections. Cold Spring Harb. Perspect. Biol. 2012, 4. [CrossRef][PubMed]
20. Kramann, R.; Kusaba, T.; Humphreys, B.D. Who regenerates the kidney tubule? Nephrol. Dial. Transplant. 2015, 30, 903–910. [CrossRef][PubMed]
21. Bonventre, J.V. Dedifferentiation and proliferation of surviving epithelial cells in acute renal failure. J. Am. Soc. Nephrol. JASN 2003, 14, S55–S61. [CrossRef][PubMed]
22. Kusaba, T.; Lalli, M.; Kramann, R.; Kobayashi, A.; Humphreys, B.D. Differentiated kidney epithelial cells repair injured proximal tubule. Proc. Natl. Acad. Sci. USA 2014, 111, 1527–1532. [CrossRef][PubMed]
23. Smeets, B.; Boor, P.; Dijkman, H.; Sharma, S.V.; Jirak, P.; Mooren, F.; Berger, K.; Bornemann, J.; Gelman, I.H.; Floege, J. et al. Proximal tubular cells contain a phenotypically distinct, scattered cell population involved in tubular regeneration. J. Pathol. 2013, 229, 645–659. [CrossRef][PubMed]
24. Sagrinati, C.; Netti, G.S.; Mazzinghi, B.; Lazzeri, E.; Liotta, F.; Frosali, F.; Ronconi, E.; Meini, C.; Gacci, M.; Squecco, R. et al. Isolation and characterization of multipotent progenitor cells from the Bowman’s capsule of adult human kidneys. J. Am. Soc. Nephrol. JASN 2006, 17, 2443–2456. [CrossRef][PubMed]
25. Angelotti, M.L.; Ronconi, E.; Ballerini, L.; Peired, A.; Mazzinghi, B.; Sagrinati, C.; Parente, E.; Gacci, M.; Carini, M.; Rotondi, M. et al. Characterization of renal progenitors committed toward tubular lineage and their regenerative potential in renal tubular injury. Stem Cells 2012, 30, 1714–1725. [CrossRef][PubMed]
26. Romagnani, P.; Remuzzi, G. Renal progenitors in non-diabetic and diabetic nephropathies. Trends Endocrinol. Metab. TEM 2013, 24, 13–20. [CrossRef][PubMed]
27. Lazzeri, E.; Crescioli, C.; Ronconi, E.; Mazzinghi, B.; Sagrinati, C.; Netti, G.S.; Angelotti, M.L.; Parente, E.; Ballerini, L.; Cosmi, L. et al. Regenerative potential of embryonic renal multipotent progenitors in acute renal failure. J. Am. Soc. Nephrol. JASN 2007, 18, 3128–3138. [CrossRef][PubMed]
28. Coca, S.G.; Singanamala, S.; Parikh, C.R. Chronic kidney disease after acute kidney injury: A systematic review and meta-analysis. Kidney Int. 2012, 81, 442–448. [CrossRef][PubMed]
29. Grobstein, C. Inductive epitheliomesenchymal interaction in cultured organ rudiments of the mouse. Science 1953, 118, 52–55. [CrossRef][PubMed]
30. O’Brien, L.L.; McMahon, A.P. Induction and patterning of the metanephric nephron. Semin. Cell Dev. Biol. 2014, 36, 31–38. [CrossRef][PubMed]
31. Hay, E.D. An overview of epithelio-mesenchymal transformation. Acta Anat. 1995, 154, 8–20. [CrossRef][PubMed]
32. Kreidberg, J.A.; Sariola, H.; Loring, J.M.; Maeda, M.; Pelletier, J.; Housman, D.; Jaenisch, R. WT-1 is required for early kidney development. Cell 1993, 74, 679–691. [CrossRef]
33. Torres, M.; Gomez-Pardo, E.; Dressler, G.R.; Gruss, P. Pax-2 controls multiple steps of urogenital development. Development 1995, 121, 4057–4065. [PubMed]
34. Self, M.; Lagutin, O.V.; Bowling, B.; Hendrix, J.; Cai, Y.; Dressler, G.R.; Olivier, G. Six2 is required for suppression of nephrogenesis and progenitor renewal in the developing kidney. EMBO J. 2006, 25, 5214–5228. [CrossRef][PubMed]
35. Kobayashi, A.; Valerius, M.T.; Mugford, J.W.; Carroll, T.J.; Self, M.; Oliver, G.; McMahon, A.P. Six2 defines and regulates a multipotent self-renewing nephron progenitor population throughout mammalian kidney development. Cell Stem Cell 2008, 3, 169–181. [CrossRef][PubMed]
36. Imgrund, M.; Grone, E.; Grone, H.J.; Kretzler, M.; Holzman, L.; Schlondorff, D.; Rothenpieler, U.W. Re-expression of the developmental gene Pax-2 during experimental acute tubular necrosis in mice 1. Kidney Int. 1999, 56, 1423–1431. [CrossRef][PubMed]
37. Cohen, T.; Loutochin, O.; Amin, M.; Capolicchio, J.P.; Goodyer, P.; Jednak, R. PAX2 is reactivated in urinary tract obstruction and partially protects collecting duct cells from programmed cell death. Am. J. Physiol. Ren. Physiol. 2007, 292, F1267–F1273. [CrossRef][PubMed]
38. Martinez-Estrada, O.M.; Lettice, L.A.; Essafi, A.; Guadix, J.A.; Slight, J.; Velecela, V.; Hall, E.; Reichmann, J.; Devenney, P.S.; Hohenstein, P. et al. Wt1 is required for cardiovascular progenitor cell formation through transcriptional control of Snail and E-cadherin. Nat. Genet. 2010, 42, 89–93. [CrossRef][PubMed]
39. Doerner, A.M.; Zuraw, B.L. TGF-b1 induced epithelial to mesenchymal transition (EMT) in human bronchial epithelial cells is enhanced by IL-1b but not abrogated by corticosteroids. Respir. Res. 2009, 10, 100. [CrossRef][PubMed]
40. Masszi, A.; di Ciano, C.; Sirokmany, G.; Arthur, W.T.; Rotstein, O.D.; Wang, J.; McCulloch, C.A.; Rosivall, L.; Mucsi, I.; Kapus, A. Central role for Rho in TGF-b1-induced b-smooth muscle actin expression during epithelial-mesenchymal transition. Am. J. Physiol. Ren. Physiol. 2003, 284, F911–F924. [CrossRef][PubMed]
41. Fan, J.M.; Ng, Y.Y.; Hill, P.A.; Nikolic-Paterson, D.J.; Mu, W.; Atkins, R.C.; Lan, H.Y. Transforming growth factor-b regulates tubular epithelial-myofibroblast transdifferentiation in vitro. Kidney Int. 1999, 56, 1455–1467. [CrossRef][PubMed]
42. Hosper, N.A.; van den Berg, P.P.; de Rond, S.; Popa, E.R.; Wilmer, M.J.; Masereeuw, R.; Bank, R.A. Epithelial-to-mesenchymal transition in fibrosis: Collagen type I expression is highly upregulated after EMT, but does not contribute to collagen deposition. Exp. Cell Res. 2013, 319, 3000–3009. [CrossRef][PubMed]
43. Iwano, M.; Plieth, D.; Danoff, T.M.; Xue, C.; Okada, H.; Neilson, E.G. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J. Clin. Investig. 2002, 110, 341–350. [CrossRef][PubMed]
44. Strutz, F.; Okada, H.; Lo, C.W.; Danoff, T.; Carone, R.L.; Tomaszewski, J.E.; Neilson, E.G. Identification and characterization of a fibroblast marker: FSP1. J. Cell Biol. 1995, 130, 393–405. [CrossRef][PubMed]
45. Okada, H.; Danoff, T.M.; Kalluri, R.; Neilson, E.G. Early role of Fsp1 in epithelial-mesenchymal transformation. Am. J. Physiol. 1997, 273, F563–F574. [PubMed]
46. Kong, P.; Christia, P.; Saxena, A.; Su, Y.; Frangogiannis, N.G. Lack of specificity of fibroblast-specific protein 1 in cardiac remodeling and fibrosis. Am. J. Physiol. Heart Circ. Physiol. 2013, 305, H1363–H1372. [CrossRef][PubMed]
47. Osterreicher, C.H.; Penz-Osterreicher, M.; Grivennikov, S.I.; Guma, M.; Koltsova, E.K.; Datz, C.; Sasik, R.; Hardiman, G.; Karin, M.; Brenner, D.A. Fibroblast-specific protein 1 identifies an inflammatory subpopulation of macrophages in the liver. Proc. Natl. Acad. Sci. USA 2011, 108, 308–313. [CrossRef][PubMed]
48. Le Hir, M.; Hegyi, I.; Cueni-Loffing, D.; Loffing, J.; Kaissling, B. Characterization of renal interstitial fibroblast-specific protein 1/S100A4-positive cells in healthy and inflamed rodent kidneys. Histochem. Cell Biol. 2005, 123, 335–346. [CrossRef][PubMed]
49. Inoue, T.; Plieth, D.; Venkov, C.D.; Xu, C.; Neilson, E.G. Antibodies against macrophages that overlap in specificity with fibroblasts. Kidney Int. 2005, 67, 2488–2493. [CrossRef][PubMed]
50. LeBleu, V.S.; Taduri, G.; O’Connell, J.; Teng, Y.; Cooke, V.G.; Woda, C.; Sugimoto, H.; Kalluri, R. Origin and function of myofibroblasts in kidney fibrosis. Nat. Med. 2013, 19, 1047–1053. [CrossRef][PubMed]
51. Koesters, R.; Kaissling, B.; Lehir, M.; Picard, N.; Theilig, F.; Gebhardt, R.; Glick, A.B.; Hahnel, B.; Hosser, H.; Grone, H.J. et al. Tubular overexpression of transforming growth factor-b1 induces autophagy and fibrosis but not mesenchymal transition of renal epithelial cells. Am. J. Pathol. 2010, 177, 632–643. [CrossRef][PubMed]
52. Humphreys, B.D.; Lin, S.L.; Kobayashi, A.; Hudson, T.E.; Nowlin, B.T.; Bonventre, J.V.; Valerius, M.T.; McMahon, A.P.; Duffield, J.S. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am. J. Pathol. 2010, 176, 85–97. [CrossRef][PubMed]
53. Li, L.; Zepeda-Orozco, D.; Black, R.; Lin, F. Autophagy is a component of epithelial cell fate in obstructive uropathy. Am. J. Pathol. 2010, 176, 1767–1778. [CrossRef][PubMed]
54. Nakasatomi, M.; Maeshima, A.; Mishima, K.; Ikeuchi, H.; Sakairi, T.; Kaneko, Y.; Hiromura, K.; Nojima, Y. Novel approach for the detection of tubular cell migration into the interstitium during renal fibrosis in rats. Fibrogenesis Tissue Repair 2015, 8, 12. [CrossRef][PubMed]
55. Mack, M.; Yanagita, M. Origin of myofibroblasts and cellular events triggering fibrosis. Kidney Int. 2015, 87, 297–307. [CrossRef][PubMed]
56. Kriz, W.; Kaissling, B.; le Hir, M. Epithelial-mesenchymal transition (EMT) in kidney fibrosis: Fact or fantasy? J. Clin. Investig. 2011, 121, 468–474. [CrossRef][PubMed]
57. Grande, M.T.; Sanchez-Laorden, B.; Lopez-Blau, C.; de Frutos, C.A.; Boutet, A.; Arevalo, M.; Rowe, R.G.; Weiss, S.J.; Lopez-Novoa, J.M.; Nieto, M.A. Snail1-induced partial epithelial-to-mesenchymal transition drives renal fibrosis in mice and can be targeted to reverse established disease. Nat. Med. 2015, 21, 989–997. [CrossRef][PubMed]
58. Anglani, F.; Ceol, M.; Mezzabotta, F.; Torregrossa, R.; Tiralongo, E.; Tosetto, E.; Del Prete, D.; D’Angelo, A. The renal stem cell system in kidney repair and regeneration. Front. Biosci. A J. Virtual Libr. 2008, 13, 6395–6405. [CrossRef]
59. Jiang, Y.S.; Jiang, T.; Huang, B.; Chen, P.S.; Ouyang, J. Epithelial-mesenchymal transition of renal tubules: Divergent processes of repairing in acute or chronic injury? Med. Hypotheses 2013, 81, 73–75. [CrossRef][PubMed]
60. Swetha, G.; Chandra, V.; Phadnis, S.; Bhonde, R. Glomerular parietal epithelial cells of adult murine kidney undergo EMT to generate cells with traits of renal progenitors. J. Cell. Mol. Med. 2011, 15, 396–413. [PubMed]
61. Huang, B.; Pi, L.; Chen, C.; Yuan, F.; Zhou, Q.; Teng, J.; Jiang, T. WT1 and Pax2 re-expression is required for epithelial-mesenchymal transition in 5/6 nephrectomized rats and cultured kidney tubular epithelial cells. Cells Tissues Organs 2012, 195, 296–312. [CrossRef][PubMed]
62. Jiang, Y.; Jiang, T.; Ouyang, J.; Zhou, Q.; Liang, Y.; Cui, Y.; Chen, P.; Huang, B. Cell atavistic transition: Paired box 2 re-expression occurs in mature tubular epithelial cells during acute kidney injury and is regulated by Angiotensin II. PLoS ONE 2014, 9, e93563. [CrossRef][PubMed]
63. Hendry, C.E.; Vanslambrouck, J.M.; Ineson, J.; Suhaimi, N.; Takasato, M.; Rae, F.; Little, M.H. Direct transcriptional reprogramming of adult cells to embryonic nephron progenitors. J. Am. Soc. Nephrol. JASN 2013, 24, 1424–1434. [CrossRef][PubMed]
64. Leroy, P.; Mostov, K.E. Slug is required for cell survival during partial epithelial-mesenchymal transition of HGF-induced tubulogenesis. Mol. Biol. Cell 2007, 18, 1943–1952. [CrossRef][PubMed]
65. Tran, H.D.; Luitel, K.; Kim, M.; Zhang, K.; Longmore, G.D.; Tran, D.D. Transient SNAIL1 expression is necessary for metastatic competence in breast cancer. Cancer Res. 2014, 74, 6330–6340. [CrossRef][PubMed]
66. De Chiara, L.; Fagoonee, S.; Ranghino, A.; Bruno, S.; Camussi, G.; Tolosano, E.; Silengo, L.; Altruda, F. Renal cells from spermatogonial germline stem cells protect against kidney injury. J. Am. Soc. Nephrol. JASN 2014, 25, 316–328. [CrossRef][PubMed]
67. Maetzel, D.; Sarkar, S.; Wang, H.; Abi-Mosleh, L.; Xu, P.; Cheng, A.W.; Gao, Q.; Mitalipova, M.; Jaenisch, R. Genetic and chemical correction of cholesterol accumulation and impaired autophagy in hepatic and neural cells derived from Niemann-Pick Type C patient-specific iPS cells. Stem Cell Rep 2014, 2, 866–880. [CrossRef][PubMed]
68. Reinhardt, P.; Schmid, B.; Burbulla, L.F.; Schondorf, D.C.; Wagner, L.; Glatza, M.; Hoing, S.; Hargus, G.; Heck, S.A.; Dhingra, A. et al. Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression. Cell Stem Cell 2013, 12, 354–367. [CrossRef][PubMed]
69. Alves, C.J.; Dariolli, R.; Jorge, F.M.; Monteiro, M.R.; Maximino, J.R.; Martins, R.S.; Strauss, B.E.; Krieger, J.E.; Callegaro, D.; Chadi, G. Gene expression profiling for human iPS-derived motor neurons from sporadic ALS patients reveals a strong association between mitochondrial functions and neurodegeneration. Front. Cell. Neurosci. 2015, 9, 289. [CrossRef][PubMed]
70. Kaufmann, M.; Schuffenhauer, A.; Fruh, I.; Klein, J.; Thiemeyer, A.; Rigo, P.; Gomez-Mancilla, B.; Heidinger-Millot, V.; Bouwmeester, T.; Schopfer, U. et al. High-Throughput Screening Using iPSC-Derived Neuronal Progenitors to Identify Compounds Counteracting Epigenetic Gene Silencing in Fragile X Syndrome. J. Biomol. Screen. 2015, 20, 1101–1111. [CrossRef][PubMed]
71. Singh, V.K.; Kalsan, M.; Kumar, N.; Saini, A.; Chandra, R. Induced pluripotent stem cells: Applications in regenerative medicine, disease modeling, and drug discovery. Front. Cell Dev. Biol. 2015, 3, 2. [CrossRef][PubMed]
72. Hanna, J.; Saha, K.; Pando, B.; van Zon, J.; Lengner, C.J.; Creyghton, M.P.; van Oudenaarden, A.; Jaenisch, R. Direct cell reprogramming is a stochastic process amenable to acceleration. Nature 2009, 462, 595–601. [CrossRef][PubMed]
73. Hu, K. All roads lead to induced pluripotent stem cells: The technologies of iPSC generation. Stem Cells Dev. 2014, 23, 1285–1300. [CrossRef][PubMed]
74. Ruetz, T.; Kaji, K. Routes to induced pluripotent stem cells. Curr. Opin. Genet. Dev. 2014, 28, 38–42. [CrossRef][PubMed]
75. Revilla, A.; Gonzalez, C.; Iriondo, A.; Fernandez, B.; Prieto, C.; Marin, C.; Liste, I. Current advances in the generation of human iPS cells: Implications in cell-based regenerative medicine. J. Tissue Eng. Regen. Med. 2015. [CrossRef][PubMed]
76. Csobonyeiova, M.; Polak, S.; Koller, J.; Danisovic, L. Induced pluripotent stem cells and their implication for regenerative medicine. Cell Tissue Bank. 2015, 16, 171–180. [CrossRef][PubMed]
77. Malik, N.; Rao, M.S. A review of the methods for human iPSC derivation. Methods Mol. Biol. 2013, 997, 23–33. [PubMed]
78. Marson, A.; Levine, S.S.; Cole, M.F.; Frampton, G.M.; Brambrink, T.; Johnstone, S.; Guenther, M.G.; Johnston, W.K.; Wernig, M.; Newman, J. et al. Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells. Cell 2008, 134, 521–533. [CrossRef][PubMed]
79. Card, D.A.; Hebbar, P.B.; Li, L.; Trotter, K.W.; Komatsu, Y.; Mishina, Y.; Archer, T.K. Oct4/Sox2-regulated miR-302 targets cyclin D1 in human embryonic stem cells. Mol. Cell. Biol. 2008, 28, 6426–6438. [CrossRef][PubMed]
80. Anokye-Danso, F.; Trivedi, C.M.; Juhr, D.; Gupta, M.; Cui, Z.; Tian, Y.; Zhang, Y.; Yang, W.; Gruber, P.J.; Epstein, J.A. et al. Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell 2011, 8, 376–388. [CrossRef][PubMed]
81. Hu, S.; Wilson, K.D.; Ghosh, Z.; Han, L.; Wang, Y.; Lan, F.; Ransohoff, K.J.; Burridge, P.; Wu, J.C. MicroRNA-302 increases reprogramming efficiency via repression of NR2F2. Stem Cells 2013, 31, 259–268. [CrossRef][PubMed]
82. Subramanyam, D.; Lamouille, S.; Judson, R.L.; Liu, J.Y.; Bucay, N.; Derynck, R.; Blelloch, R. Multiple targets of miR-302 and miR-372 promote reprogramming of human fibroblasts to induced pluripotent stem cells. Nat. Biotechnol. 2011, 29, 443–448. [CrossRef][PubMed]
83. Lipchina, I.; Studer, L.; Betel, D. The expanding role of miR-302-367 in pluripotency and reprogramming. Cell Cycle 2012, 11, 1517–1523. [CrossRef][PubMed]
84. Faherty, N.; Curran, S.P.; O’Donovan, H.; Martin, F.; Godson, C.; Brazil, D.P.; Crean, J.K. CCN2/CTGF increases expression of miR-302 microRNAs, which target the TGFb type II receptor with implications for nephropathic cell phenotypes. J. Cell Sci. 2012, 125, 5621–5629. [CrossRef][PubMed]
85. De Chiara, L.; Andrews, D.; Godson, C.; Crean, J. Targeting the Polycomb Repressor Complex Chromatin Remodeling Machinery for Therapeutic Benefit in Diabetic Nephropathy; American Society of Nephrology, ASN, Kidney Week: San Diego, CA, USA, 2015.
86. Gill, J.G.; Langer, E.M.; Lindsley, R.C.; Cai, M.; Murphy, T.L.; Kyba, M.; Murphy, K.M. Snail and the microRNA-200 family act in opposition to regulate epithelial-to-mesenchymal transition and germ layer fate restriction in differentiating ESCs. Stem Cells 2011, 29, 764–776. [CrossRef][PubMed]
87. Unternaehrer, J.J.; Zhao, R.; Kim, K.; Cesana, M.; Powers, J.T.; Ratanasirintrawoot, S.; Onder, T.; Shibue, T.; Weinberg, R.A.; Daley, G.Q. The epithelial-mesenchymal transition factor SNAIL paradoxically enhances reprogramming. Stem Cell Rep. 2014, 3, 691–698. [CrossRef][PubMed]
88. Samavarchi-Tehrani, P.; Golipour, A.; David, L.; Sung, H.K.; Beyer, T.A.; Datti, A.; Woltjen, K.; Nagy, A.; Wrana, J.L. Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming. Cell Stem Cell 2010, 7, 64–77. [CrossRef][PubMed]
89. Melton, C.; Judson, R.L.; Blelloch, R. Opposing microRNA families regulate self-renewal in mouse embryonic stem cells. Nature 2010, 463, 621–626. [CrossRef][PubMed]
90. Li, M.A.; He, L. microRNAs as novel regulators of stem cell pluripotency and somatic cell reprogramming. Bioessays 2012, 34, 670–680. [CrossRef][PubMed]
91. Maherali, N.; Ahfeldt, T.; Rigamonti, A.; Utikal, J.; Cowan, C.; Hochedlinger, K. A high-efficiency system for the generation and study of human induced pluripotent stem cells. Cell Stem Cell 2008, 3, 340–345. [CrossRef][PubMed]
92. Raab, S.; Klingenstein, M.; Liebau, S.; Linta, L. A Comparative View on Human Somatic Cell Sources for iPSC Generation. Stem Cells Int. 2014, 2014, 768391. [CrossRef][PubMed]
93. Gingold, J.A.; Fidalgo, M.; Guallar, D.; Lau, Z.; Sun, Z.; Zhou, H.; Faiola, F.; Huang, X.; Lee, D.F.; Waghray, A. et al. A genome-wide RNAi screen identifies opposing functions of Snai1 and Snai2 on the Nanog dependency in reprogramming. Mol. Cell 2014, 56, 140–152. [CrossRef][PubMed]
94. Tessarz, P.; Kouzarides, T. Histone core modifications regulating nucleosome structure and dynamics. Nat. Rev. Mol. Cell Biol. 2014, 15, 703–708. [CrossRef][PubMed]
95. Musselman, C.A.; Lalonde, M.E.; Cote, J.; Kutateladze, T.G. Perceiving the epigenetic landscape through histone readers. Nat. Struct. Mol. Biol. 2012, 19, 1218–1227. [CrossRef][PubMed]
96. Consortium E.P. An integrated encyclopedia of DNA elements in the human genome. Nature 2012, 489, 57–74.
97. Zhou, V.W.; Goren, A.; Bernstein, B.E. Charting histone modifications and the functional organization of mammalian genomes. Nat. Rev. Genet. 2011, 12, 7–18. [CrossRef][PubMed]
98. Kouzarides, T. Chromatin modifications and their function. Cell 2007, 128, 693–705. [CrossRef][PubMed]
99. Voigt, P.; LeRoy, G.; Drury, W.J., 3rd; Zee, B.M.; Son, J.; Beck, D.B.; Young, N.L.; Garcia, B.A.; Reinberg, D. Asymmetrically modified nucleosomes. Cell 2012, 151, 181–193. [CrossRef][PubMed]
100. Bernstein, B.E.; Mikkelsen, T.S.; Xie, X.; Kamal, M.; Huebert, D.J.; Cuff, J.; Fry, B.; Meissner, A.; Wernig, M.; Plath, K. et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 2006, 125, 315–326. [CrossRef][PubMed]
101. Van Kruijsbergen, I.; Hontelez, S.; Veenstra, G.J. Recruiting polycomb to chromatin. Int. J. Biochem. Cell Biol. 2015, 67, 177–187. [CrossRef][PubMed]
102. Gonzalez, M.E.; Moore, H.M.; Li, X.; Toy, K.A.; Huang, W.; Sabel, M.S.; Kidwell, K.M.; Kleer, C.G. EZH2 expands breast stem cells through activation of NOTCH1 signaling. Proc. Natl. Acad. Sci. USA 2014, 111, 3098–3103. [CrossRef][PubMed]
103. Volkel, P.; Dupret, B.; le Bourhis, X.; Angrand, P.O. Diverse involvement of EZH2 in cancer epigenetics. Am. J. Transl. Res. 2015, 7, 175–193. [PubMed]
104. Tong, Z.T.; Cai, M.Y.; Wang, X.G.; Kong, L.L.; Mai, S.J.; Liu, Y.H.; Zhang, H.B.; Liao, Y.J.; Zheng, F.; Zhu, W. et al. EZH2 supports nasopharyngeal carcinoma cell aggressiveness by forming a co-repressor complex with HDAC1/HDAC2 and Snail to inhibit E-cadherin. Oncogene 2012, 31, 583–594. [CrossRef][PubMed]
105. Liu, L.; Xu, Z.; Zhong, L.; Wang, H.; Jiang, S.; Long, Q.; Xu, J.; Guo, J. Enhancer of zeste homolog 2 (EZH2) promotes tumour cell migration and invasion via epigenetic repression of E-cadherin in renal cell carcinoma. BJU Int. 2014. [CrossRef][PubMed]
106. Wang, C.; Liu, X.; Chen, Z.; Huang, H.; Jin, Y.; Kolokythas, A.; Wang, A.; Dai, Y.; Wong, D.T.; Zhou, X. Polycomb group protein EZH2-mediated E-cadherin repression promotes metastasis of oral tongue squamous cell carcinoma. Mol. Carcinog. 2013, 52, 229–236. [CrossRef][PubMed]
107. Cao, Q.; Yu, J.; Dhanasekaran, S.M.; Kim, J.H.; Mani, R.S.; Tomlins, S.A.; Mehra, R.; Laxman, B.; Cao, X.; Yu, J. et al. Repression of E-cadherin by the polycomb group protein EZH2 in cancer. Oncogene 2008, 27, 7274–7284. [CrossRef][PubMed]
108. Herranz, N.; Pasini, D.; Diaz, V.M.; Franci, C.; Gutierrez, A.; Dave, N.; Escriva, M.; Hernandez-Munoz, I.; Di Croce, L.; Helin, K. et al. Polycomb complex 2 is required for E-cadherin repression by the Snail1 transcription factor. Mol. Cell. Biol. 2008, 28, 4772–4781. [CrossRef][PubMed]
109. Tien, C.L.; Jones, A.; Wang, H.; Gerigk, M.; Nozell, S.; Chang, C. Snail2/Slug cooperates with Polycomb repressive complex 2 (PRC2) to regulate neural crest development. Development 2015, 142, 722–731. [CrossRef][PubMed]
110. Oktyabri, D.; Tange, S.; Terashima, M.; Ishimura, A.; Suzuki, T. EED regulates epithelial-mesenchymal transition of cancer cells induced by TGF-b. Biochem. Biophys. Res. Commun. 2014, 453, 124–130. [CrossRef][PubMed]
111. Zhang, J.; Taylor, R.J.; La Torre, A.; Wilken, M.S.; Cox, K.E.; Reh, T.A.; Vetter, M.L. Ezh2 maintains retinal progenitor proliferation, transcriptional integrity, and the timing of late differentiation. Dev. Biol. 2015, 403, 128–138. [CrossRef][PubMed]
112. Ezhkova, E.; Pasolli, H.A.; Parker, J.S.; Stokes, N.; Su, I.H.; Hannon, G.; Tarakhovsky, A.; Fuchs, E. Ezh2 orchestrates gene expression for the stepwise differentiation of tissue-specific stem cells. Cell 2009, 136, 1122–1135. [CrossRef][PubMed]
113. Metsuyanim, S.; Pode-Shakked, N.; Schmidt-Ott, K.M.; Keshet, G.; Rechavi, G.; Blumental, D.; Dekel, B. Accumulation of malignant renal stem cells is associated with epigenetic changes in normal renal progenitor genes. Stem Cells 2008, 26, 1808–1817. [CrossRef][PubMed]
114. McLaughlin, N.; Wang, F.; Saifudeen, Z.; el-Dahr, S.S. In situ histone landscape of nephrogenesis. Epigenetics 2014, 9, 222–235. [CrossRef][PubMed]
115. Buzhor, E.; Omer, D.; Harari-Steinberg, O.; Dotan, Z.; Vax, E.; Pri-Chen, S.; Metsuyanim, S.; Pleniceanu, O.; Goldstein, R.S.; Dekel, B. Reactivation of NCAM1 defines a subpopulation of human adult kidney epithelial cells with clonogenic and stem/progenitor properties. Am. J. Pathol. 2013, 183, 1621–1633. [CrossRef][PubMed]
116. Rao, R.A.; Dhele, N.; Cheemadan, S.; Ketkar, A.; Jayandharan, G.R.; Palakodeti, D.; Rampalli, S. Ezh2 mediated H3K27me3 activity facilitates somatic transition during human pluripotent reprogramming. Sci. Rep. 2015, 5, 8229. [CrossRef][PubMed]
117. Akpa, M.M.; Iglesias, D.M.; Chu, L.L.; Cybulsky, M.; Bravi, C.; Goodyer, P.R. Wilms tumor suppressor, WT1, suppresses epigenetic silencing of the b-catenin gene. J. Biol. Chem. 2015, 290, 2279–2288. [CrossRef][PubMed]
118. Tange, S.; Oktyabri, D.; Terashima, M.; Ishimura, A.; Suzuki, T. JARID2 is involved in transforming growth factor-_-induced epithelial-mesenchymal transition of lung and colon cancer cell lines. PLoS ONE 2014, 9, e115684. [CrossRef][PubMed]
119. Ke, X.S.; Qu, Y.; Cheng, Y.; Li, W.C.; Rotter, V.; Oyan, A.M.; Kalland, K.H. Global profiling of histone and DNA methylation reveals epigenetic-based regulation of gene expression during epithelial to mesenchymal transition in prostate cells. BMC Genom. 2010, 11, 669. [CrossRef][PubMed]
120. Zheng, M.; Jiang, Y.P.; Chen, W.; Li, K.D.; Liu, X.; Gao, S.Y.; Feng, H.; Wang, S.S.; Jiang, J.; Ma, X.R. et al. Snail and Slug collaborate on EMT and tumor metastasis through miR-101-mediated EZH2 axis in oral tongue squamous cell carcinoma. Oncotarget 2015, 6, 6797–6810. [CrossRef][PubMed]
121. Peinado, H.; Quintanilla, M.; Cano, A. Transforming growth factor b-1 induces snail transcription factor in epithelial cell lines: Mechanisms for epithelial mesenchymal transitions. J. Biol. Chem. 2003, 278, 21113–21123. [CrossRef][PubMed]
122. Watabe, T.; Miyazono, K. Roles of TGF-b family signaling in stem cell renewal and differentiation. Cell Res. 2009, 19, 103–115. [CrossRef][PubMed]
123. Huang, S.S.; Huang, J.S. TGF-b control of cell proliferation. J. Cell. Biochem. 2005, 96, 447–462. [CrossRef][PubMed]
124. Jang, C.W.; Chen, C.H.; Chen, C.C.; Chen, J.Y.; Su, Y.H.; Chen, R.H. TGF-b induces apoptosis through Smad-mediated expression of DAP-kinase. Nat. Cell Biol. 2002, 4, 51–58. [CrossRef][PubMed]
125. Wu, M.Y.; Hill, C.S. TGF-b superfamily signaling in embryonic development and homeostasis. Dev. Cell 2009, 16, 329–343. [CrossRef][PubMed]
126. Mullen, A.C.; Orlando, D.A.; Newman, J.J.; Loven, J.; Kumar, R.M.; Bilodeau, S.; Reddy, J.; Guenther, M.G.; DeKoter, R.P.; Young, R.A. Master transcription factors determine cell-type-specific responses to TGF-b signaling. Cell 2011, 147, 565–576. [CrossRef][PubMed]
127. Ruetz, T.; Pfisterer, U.; DiStefano, B.; Johnsson, A.; Choen, E.; Linnarsson, S.; Graf, T.; Parmar, M.; Kaji, K. Identification of a potent signaling pathway that orchestrates both reprogramming and transdifferentiation. In Proceedings of the International Society for Stem Cell Research, Annual Meeting 2015, Stockholm, Sweden, 26 June 2015.
128. Andrews, D.; Oliviero, G.; de Chiara, L.; Cagney, G.; Crean, J. University College Dublin, Dublin, Ireland. Unpublished work. 2015.